Fundz

Who to call at Cipla, and when

Fundz watches for the moments Cipla starts buying, and tells you who to reach.

  • An alert the day Cipla raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cipla, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cipla. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Cipla partners with Qilu Pharma to exclusively commercialize QL2107, a biosimilar to pembrolizumab, in the US.

Sep 04, 2026

Contract Type

partnership

MumbaiManufacturingBiotechnologyHealth CarePharmaceuticalpharmaceuticals

Description

Cipla's subsidiary Invagen Pharmaceuticals has formed a strategic partnership with Qilu Pharmaceutical for the exclusive licensing and supply of QL2107 in the United States. Qilu will lead development and regulatory processes, while Cipla USA Inc. will handle commercialization efforts.

Company Information

Company

Cipla

Location

Ganpatrao Kadam Marg

Mumbai, Maharashtra, India

About

Cipla is a global pharmaceutical company based in India. The company specializes in the production and distribution of a wide range of medications, including generic and branded drugs. Cipla is committed to providing accessible healthcare solutions and has a presence in many international markets.

Related People

Umang
Senior decision-maker at this company
••••••••@••••••••

See Umang's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cipla's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Cipla signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.